ESIFX
Price
$12.06
Change
-$0.04 (-0.33%)
Updated
Dec 17 closing price
PACLX
Price
$38.15
Change
-$0.16 (-0.42%)
Updated
Dec 17 closing price
Ad is loading...

ESIFX vs PACLX

Header iconESIFX vs PACLX Comparison
Open Charts ESIFX vs PACLXBanner chart's image
Eaton Vance Balanced R6
Price$12.06
Change-$0.04 (-0.33%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Capital Appreciation Adv
Price$38.15
Change-$0.16 (-0.42%)
VolumeN/A
CapitalizationN/A
ESIFX vs PACLX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESIFX vs. PACLX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESIFX is a StrongBuy and PACLX is a StrongBuy.

FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 66.4B vs. ESIFX (1.03B). PACLX pays higher dividends than ESIFX: PACLX (1.77) vs ESIFX (1.63). ESIFX was incepted earlier than PACLX: ESIFX (9 years) vs PACLX (20 years). PACLX is a more actively managed with annual turnover of: 65.10 vs. ESIFX (2.00). PACLX has a lower initial minimum investment than ESIFX: PACLX (2500) vs ESIFX (5000000). ESIFX annual gain was more profitable for investors over the last year : 18.66 vs. PACLX (13.32). ESIFX return over 5 years is better than : 31.07 vs. PACLX (29.42).
ESIFXPACLXESIFX / PACLX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years20 years-
Gain YTD17.64214.256124%
Front LoadN/AN/A-
Min. Initial Investment50000002500200,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.03B66.4B2%
Annual Yield % from dividends1.631.7792%
Returns for 1 year18.6613.32140%
Returns for 3 years11.749.68121%
Returns for 5 years31.0729.42106%
Returns for 10 yearsN/A62.56-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLSI13.010.11
+0.85%
Greenwich LifeSciences
TXT80.07-1.27
-1.56%
Textron
FBP19.45-0.61
-3.04%
First BanCorp
IMNM12.02-0.42
-3.38%
Immunome
CTHR1.52-0.14
-8.43%
Charles & Colvard Ltd.